Skip to main content
Caplight Logo









EcoPhage

EcoPhage

Private
Ness ZionaFrontier & Industrial Techhttps://ecophage.com/

Last Round

Grant

Nov 20, 2023

Total Funding Raised

$2.57M

Company Overview

EcoPhage is an agri-biotechnology company that develops sustainable and effective, phage-based crop protection solutions to manage bacterial plant diseases.

Sector

Frontier & Industrial Tech

Verticals

Biotechnology, Drug Discovery, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

phage biopesticidesbacteriophagesbiopesticidesagri-biotechbactericidesphage technologycrop protectionphage cocktailschemical pesticide alternativesustainable agriculturephage therapy for plantsplant disease controlphage discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EcoPhage Comparables

Compare EcoPhage with similar companies based on industry and business-model similarity.

EcoPhage comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phagelux AgriHealth
89%
Exacta BioScience
80%
Enviroinvest Zrt.
75%

EcoPhage Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 20, 2023
VC RoundNov 22, 2022
GrantAug 1, 2022
AcceleratorJul 26, 2021
SeedJul 10, 2019

Key People

Founding team and executive leadership

Guy Elitzur

CEO

Executive Team

EcoPhage Investors

Notable investors and investment history

EcoPhage investors
InvestorRounds
Israel Innovation AuthorityGrant
Israel Innovation AuthorityGrant, Seed
MassChallenge IsraelAccelerator
The Trendlines GroupVC Round, Follow-on Offering, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 20, 2025

    Developing a bacteriophage platform for agricultural applications.

  • Sep 20, 2025

    Dr. Lu Wei Liu appointed to the Board of Directors.

Recent news

Latest coverage and updates

  • partners_withSep 24, 2026

    EcoPhage Ltd. partnered with CNI Ag on Sep 24th '26.

  • launchesSep 16, 2026

    EcoPhage Ltd. launched GoldenEco on Sep 16th '26.

EcoPhage Filings

Explore SEC and related filing metadata, where available.

EcoPhage filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about EcoPhage's valuation, stock price, and market status.

Is EcoPhage a public or private company?

EcoPhage is a private company.

What is the current stock price of EcoPhage?

EcoPhage is a private company with no public stock price. No recent secondary market data is available.

How much is EcoPhage worth (valuation)?

Valuation information for EcoPhage is not publicly available.

Can I buy EcoPhage stock?

EcoPhage shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was EcoPhage's last funding round?

EcoPhage's most recent funding round was Grant on November 20, 2023.

Who are the main investors in EcoPhage?

Key investors in EcoPhage include The Trendlines Group.

Will EcoPhage IPO soon?

No public IPO plans have been announced for EcoPhage.

How can I track EcoPhage secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor EcoPhage's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNess Ziona
Employee Range9
Year Founded2018
Last FundingNov 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?